2.1(top 20%)
2-year impact
7.4K(top 5%)
PR articles
201.5K(top 5%)
PR citations
171(top 2%)
PR h-index
186(top 2%)
h-index
2.1(top 20%)
2-YI (no self-cite.)
9.1K
documents
272.5K
doc citations

Top Articles

#TitleJournalYearCitations
1International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung AdenocarcinomaJournal of Thoracic Oncology20113,511
2The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology20163,449
3The 2015 World Health Organization Classification of Lung TumorsJournal of Thoracic Oncology20153,402
4Receiver Operating Characteristic Curve in Diagnostic Test AssessmentJournal of Thoracic Oncology20103,386
5The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology20072,542
6The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015Journal of Thoracic Oncology20221,125
7A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)Journal of Thoracic Oncology20141,113
8PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison ProjectJournal of Thoracic Oncology2017969
9The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology2009840
10The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung CancerJournal of Thoracic Oncology2007690
11PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 ProjectJournal of Thoracic Oncology2018598
12The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology2015579
13The International Epidemiology of Lung Cancer: Geographical Distribution and Secular TrendsJournal of Thoracic Oncology2008574
14The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung CancerJournal of Thoracic Oncology2016559
15A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)Journal of Thoracic Oncology2011538
16Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR MutationJournal of Thoracic Oncology2015529
17Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging PrimerJournal of Thoracic Oncology2017528
18The International Association for the Study of Lung Cancer Lung Cancer Staging ProjectJournal of Thoracic Oncology2015522
19Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung AdenocarcinomasJournal of Thoracic Oncology2015521
20The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology2007505
21Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung CancerJournal of Thoracic Oncology2012502
22The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung CancerJournal of Thoracic Oncology2011491
23Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerJournal of Thoracic Oncology2021490
24A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407Journal of Thoracic Oncology2020483
25Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma ClassificationJournal of Thoracic Oncology2011482
26Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLCJournal of Thoracic Oncology2018478
27Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III TrialJournal of Thoracic Oncology2020475
28A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLCJournal of Thoracic Oncology2018445
29The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLCJournal of Thoracic Oncology2019443
30The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor CharacteristicsJournal of Thoracic Oncology2016442
31The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology2007441
32The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and ChangesJournal of Thoracic Oncology2015440
33Epidemiology of Thymoma and Associated MalignanciesJournal of Thoracic Oncology2010431
34The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor GrowthJournal of Thoracic Oncology2011430
35A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology CommitteeJournal of Thoracic Oncology2020418
36Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging ProjectJournal of Thoracic Oncology2008416
37SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic CharacterizationJournal of Thoracic Oncology2020409
38IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLCJournal of Thoracic Oncology2021407
39Biomarkers in Lung Cancer Screening: Achievements, Promises, and ChallengesJournal of Thoracic Oncology2019396
40Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database SurveyJournal of Thoracic Oncology2010387
41The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung CancerJournal of Thoracic Oncology2017383
42The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming Seventh Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology2007382
43PD-L1 Expression in Lung CancerJournal of Thoracic Oncology2016379
44Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 TrialJournal of Thoracic Oncology2021368
45microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung CancerJournal of Thoracic Oncology2013357
46The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non–Small Cell Lung CancerJournal of Thoracic Oncology2016354
47The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung CancerJournal of Thoracic Oncology2007350
48Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX StudyJournal of Thoracic Oncology2019348
49IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant TherapyJournal of Thoracic Oncology2020347
50Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese PatientsJournal of Thoracic Oncology2013342